甲基环戊烯醇酮实验试剂, 主要用于学校,科研单位,医院等科研实验。
公司专业经营生产抗体、细胞、标准品、对照品、elisa试剂盒。产品深受广大客户喜爱,自2011年开始,公司实行‘万件产品,无假货’,我们承诺:凡是购买我们的产品,出现质量问题,无条件退换货,活动欢迎大家来电咨询购买。
产品详细资料:
甲基环戊烯醇酮英文名称: 3-Methylcyclopentane-1,2-dione
cas:765-70-8
欢迎来电索取说明书和实用方法。
甲基环戊烯醇酮其他相关产品:
醋酸环丙氯地孕酮Cyproteroneacetate427-51-0>99%,EP,BR
醋酸环丙氯地孕酮Cyproteroneacetate427-51-0>99%,EP,BR
磺胺吡啶Sulfapyridine144-83-2>99%,USP30,BR
磺胺吡啶Sulfapyridine144-83-2>99%,USP30,BR
磺胺吡啶Sulfapyridine144-83-2>99%,USP30,BR
磺胺吡啶Sulfapyridine144-83-2>99%,USP30,BR
磺胺吡啶(标准品)Sulfapyridine144-83-2HPLC>98%,标准品
甲地孕酮Megestrolbase3562-63-8>98.5%,BR
甲地孕酮Megestrolbase3562-63-8>98.5%,BR
3-缩酮Estradienedione-3-keta5571-36-8>99%,BR
3-缩酮Estradienedione-3-keta5571-36-8>99%,BR
索拉非尼Sorafenibbase284461-73-0>98.5%,BR,可用于细胞培养
索拉非尼Sorafenibbase284461-73-0>98.5%,BR,可用于细胞培养
索拉非尼Sorafenibbase284461-73-0>98.5%,BR,可用于细胞培养
磷酸组胺Histaminephosphate51-74-1>98%,USP,BR
磷酸组胺Histaminephosphate51-74-1>98%,USP,BR
磷酸组胺Histaminephosphate51-74-1>98%,USP,BR
磷酸组胺Histaminephosphate51-74-1>98%,USP,BR
磷酸氯喹,氯喹二磷酸盐Chloroquinediphosphate50-63-5>98%
磷酸氯喹,氯喹二磷酸盐Chloroquinediphosphate50-63-5>98%
磷酸氯喹,氯喹二磷酸盐Chloroquinediphosphate50-63-5>98%
(-)-莨菪碱,L-天仙子胺,L-天仙子碱(-)-Hyoscyamine101-31-5>99%
(-)-莨菪碱,L-天仙子胺,L-天仙子碱(-)-Hyoscyamine101-31-5>99%
右旋糖苷/葡聚糖D70DextranD709004-54-0Mw:63000~77000,USP32
右旋糖苷/葡聚糖D70DextranD709004-54-0Mw:63000~77000,USP32
右旋糖苷/葡聚糖D70DextranD709004-54-0Mw:63000~77000,USP32
右旋糖苷/葡聚糖D40DextranD409004-54-0Mw35000to45000
右旋糖苷/葡聚糖D40DextranD409004-54-0Mw35000to45000
右旋糖苷/葡聚糖D40DextranD409004-54-0Mw35000to45000
右旋糖苷/葡聚糖D40DextranD409004-54-0Mw35000to45000
右旋糖苷/葡聚糖D20DextranD209004-54-0MW:16000~24000
右旋糖苷/葡聚糖D20DextranD209004-54-0MW:16000~24000
右旋糖苷/葡聚糖D20DextranD209004-54-0MW:16000~24000
右旋糖苷/葡聚糖D20DextranD209004-54-0MW:16000~24000
表没食子儿茶素没食子酸酯(EGCG90%)EGCG,(-)-Epigallocatechingallate/GreenTeaEGCG90989-51-5茶多酚≥98%,EGCG≥90%,咖啡因≤0.1%
表没食子儿茶素没食子酸酯(EGCG90%)EGCG,(-)-Epigallocatechingallate/GreenTeaEGCG90989-51-5茶多酚≥98%,EGCG≥90%,咖啡因≤0.1%
表没食子儿茶素没食子酸酯(EGCG90%)EGCG,(-)-Epigallocatechingallate/GreenTeaEGCG90989-51-5茶多酚≥98%,EGCG≥90%,咖啡因≤0.1%
表没食子儿茶素没食子酸酯(EGCG95%)EGCG,(-)-Epigallocatechingallate/GreenTeaExtract989-51-5茶多酚≥98%,EGCG≥95%,咖啡因≤0.1%
表没食子儿茶素没食子酸酯(EGCG95%)EGCG,(-)-Epigallocatechingallate/GreenTeaExtract989-51-5茶多酚≥98%,EGCG≥95%,咖啡因≤0.1%
表没食子儿茶素没食子酸酯(EGCG95%)EGCG,(-)-Epigallocatechingallate/GreenTeaExtract989-51-5茶多酚≥98%,EGCG≥95%,咖啡因≤0.1%
表没食子儿茶素没食子酸酯(EGCG95%)EGCG,(-)-Epigallocatechingallate/GreenTeaExtract989-51-5茶多酚≥98%,EGCG≥95%,咖啡因≤0.1%
达沙替尼一水合物DasatinibMonohydrate863127-77-9>99%,BR,可用于细胞培养
达沙替尼一水合物DasatinibMonohydrate863127-77-9>99%,BR,可用于细胞培养
达沙替尼一水合物DasatinibMonohydrate863127-77-9>99%,BR,可用于细胞培养
依西美坦Exemestane(USP)107868-30-4>99.5%,USP32
依西美坦Exemestane(USP)107868-30-4>99.5%,USP32
依西美坦Exemestane(USP)107868-30-4>99.5%,USP32
氨基比林Amidopyrine/aminopyrine58-15-1>98%,AR
马来酸氯苯那敏/扑尔敏ChlorpheniramineMaleate 113-92-8>98.5%,CP2010
马来酸氯苯那敏/扑尔敏ChlorpheniramineMaleate 113-92-8>98.5%,CP2010
马来酸氯苯那敏/扑尔敏ChlorpheniramineMaleate 113-92-8>98.5%,CP2010
血管紧张素IIAngiotensinII4474-91-3>98.0%,BR
血管紧张素IIAngiotensinII4474-91-3>98.0%,BR
血管紧张素IIAngiotensinII4474-91-3>98.0%,BR
血管紧张素IIAngiotensinII4474-91-3>98.0%,BR
维生素D3((胆骨化醇)VitaminD367-97-0>98.0%(HPLC)4000万IU/g
维生素D3((胆骨化醇)VitaminD367-97-0>98.0%(HPLC)4000万IU/g
维生素D3((胆骨化醇)VitaminD367-97-0>98.0%(HPLC)4000万IU/g
帕唑帕尼盐酸盐PazopanibHCl635702-64-6>99%,BR,可用于细胞培养
帕唑帕尼盐酸盐PazopanibHCl635702-64-6>99%,BR,可用于细胞培养
帕唑帕尼盐酸盐PazopanibHCl635702-64-6>99%,BR,可用于细胞培养
噻托溴铵Tiotropiumbromideanhydrous136310-93-5>99%,BR,无水物
噻托溴铵Tiotropiumbromideanhydrous136310-93-5>99%,BR,无水物
噻托溴铵Tiotropiumbromideanhydrous136310-93-5>99%,BR,无水物
富马酸福莫特罗(二水)Formoterolfumarate183814-30-4>98.5%,二水合物
富马酸福莫特罗(二水)Formoterolfumarate183814-30-4>98.5%,二水合物
富马酸福莫特罗(二水)Formoterolfumarate183814-30-4>98.5%,二水合物
富马酸福莫特罗(无水)Formoterolfumarate43229-80-7>98.5%,无水,EP
富马酸福莫特罗(无水)Formoterolfumarate43229-80-7>98.5%,无水,EP
富马酸福莫特罗(无水)Formoterolfumarate43229-80-7>98.5%,无水,EP
法罗培南(钠)(2.5水)Faropenemsodium122547-49-3,106560-14-9纯度>99.0%,BR
法罗培南(钠)(2.5水)Faropenemsodium122547-49-3,106560-14-9纯度>99.0%,BR
苄基肼二盐酸盐Benzylhydrazinedihydrochloride20570-96-1≥99.0%(HPLC)
苄基肼二盐酸盐Benzylhydrazinedihydrochloride20570-96-1≥99.0%(HPLC)
苄基肼二盐酸盐Benzylhydrazinedihydrochloride20570-96-1≥99.0%(HPLC)
苯甲基磺酰氟/苄磺酰氟PMSFPhenylmethylsulfonylfluoride329-98-6>98.5%
苯甲基磺酰氟/苄磺酰氟PMSFPhenylmethylsulfonylfluoride329-98-6>98.5%
苯甲基磺酰氟/苄磺酰氟PMSFPhenylmethylsulfonylfluoride329-98-6>98.5%
奥利司他(合成)Orlistat(synthesis)96829-58-2≥98.0%,BR
奥利司他(合成)Orlistat(synthesis)96829-58-2≥98.0%,BR
奥利司他(发酵)Orlistat(Fermentation)96829-58-2≥95.0%
奥利司他(发酵)Orlistat(Fermentation)96829-58-2≥95.0%
醋酸奥曲肽Octreotideacetate83150-76-9≥98%,BR
醋酸奥曲肽Octreotideacetate83150-76-9≥98%,BR
醋酸奥曲肽Octreotideacetate83150-76-9≥98%,BR
醋酸奥曲肽Octreotideacetate83150-76-9≥98%,BR
S(+)-2-氨基-1-丁醇(S)-(+)-2-Amino-1-butanol5856-62-2>99%,液态,0.944g/mL,25℃
S(+)-2-氨基-1-丁醇(S)-(+)-2-Amino-1-butanol5856-62-2>99%,液态,0.944g/mL,25℃
S(+)-2-氨基-1-丁醇(S)-(+)-2-Amino-1-butanol5856-62-2>99%,液态,0.944g/mL,25℃
D-鞘氨醇trans-D-erythro-sphingosine123-78-4纯度≥98%
D-鞘氨醇trans-D-erythro-sphingosine123-78-4纯度≥98%
糖脂;植物鞘胺醇ribophytosphingosinehydrochloride554-62-1≥98%,进口原装
糖脂;植物鞘胺醇ribophytosphingosinehydrochloride554-62-1≥98%,进口原装
甲苯磺丁脲Tolbutamide64-77-7>99%,BR,可用于细胞培养
甲苯磺丁脲Tolbutamide64-77-7>99%,BR,可用于细胞培养
甲苯磺丁脲Tolbutamide64-77-7>99%,BR,可用于细胞培养
甲苯磺丁脲Tolbutamide64-77-7>99%,BR,可用于细胞培养
奥美拉唑Omeprazole73590-58-6>99%,USP33,BR,可用于细胞培养
奥美拉唑Omeprazole73590-58-6>99%,USP33,BR,可用于细胞培养
奥美拉唑Omeprazole73590-58-6>99%,USP33,BR,可用于细胞培养
奥美拉唑(标准品)Omeprazole73590-58-6HPLC>98%,标准品
氯唑沙宗Chlorzoxazone95-25-0>98.5%,BR
氯唑沙宗Chlorzoxazone95-25-0>98.5%,BR
氯唑沙宗Chlorzoxazone95-25-0>98.5%,BR
氯唑沙宗(标准品)Chlorzoxazone95-25-0HPLC>98%,标准品
D-氨基葡萄糖盐酸盐D-Glucosaminehydrochloride66-84-2>98.5%,USP31,BR
D-氨基葡萄糖盐酸盐D-Glucosaminehydrochloride66-84-2>98.5%,USP31,BR
D-氨基葡萄糖盐酸盐D-Glucosaminehydrochloride66-84-2>98.5%,USP31,BR
氟派利多,氟哌利多Droperidol548-73-2>98%,BR,USP
氟派利多,氟哌利多Droperidol548-73-2>98%,BR,USP
6-疏基嘌呤/6-巯基嘌呤(一水合物)6-Mercaptopurinemonohydrate6112-76-1>98.5%,BR
6-疏基嘌呤/6-巯基嘌呤(一水合物)6-Mercaptopurinemonohydrate6112-76-1>98.5%,BR
6-疏基嘌呤/6-巯基嘌呤(一水合物)6-Mercaptopurinemonohydrate6112-76-1>98.5%,BR
扑热息痛/对乙酰氨基酚Paracetamol(Acetaminofenpolvo)103-90-2>98.5%,USP32
扑热息痛/对乙酰氨基酚Paracetamol(Acetaminofenpolvo)103-90-2>98.5%,USP32
扑热息痛/对乙酰氨基酚Paracetamol(Acetaminofenpolvo)103-90-2>98.5%,USP32
(R)-1-氨基-3-甲基丁基硼酸蒎烷二醇酯三氟醋酸盐(R)-BoroLeu-(+)-Pinanediol-CF3CO2H179324-87-9Assay98%,S构型杂质<0.5%
奥拉帕尼Olaparib763113-22-0≥95%,BR,可用于细胞培养
奥拉帕尼Olaparib763113-22-0≥95%,BR,可用于细胞培养
花椒毒素/8-甲氧基补骨脂素/甲氧沙林Methoxsalen/8-Methoxypsoralen298-81-7>98%,BR
花椒毒素/8-甲氧基补骨脂素/甲氧沙林Methoxsalen/8-Methoxypsoralen298-81-7>98%,BR
花椒毒素/8-甲氧基补骨脂素/甲氧沙林Methoxsalen/8-Methoxypsoralen298-81-7>98%,BR
奎尼丁Quinidine56-54-2>98.0%,BR
奎尼丁Quinidine56-54-2>98.0%,BR
奎尼丁Quinidine56-54-2>98.0%,BR
奎尼丁Quinidine56-54-2>98.0%,BR
单月桂酸甘油酯/甘油一月桂酸酯Monolaurin/1-Lauroyl-rac-glycerol142-18-7单酯含量大于40%
单月桂酸甘油酯/甘油一月桂酸酯Monolaurin/1-Lauroyl-rac-glycerol142-18-7单酯含量大于40%
甘油单油酸酯/单油酸甘油酯Monoolein111-03-5纯度≥50%,油状液体
甘油单油酸酯/单油酸甘油酯Monoolein111-03-5纯度≥50%,油状液体
5'-二磷酸腺苷二钠/腺苷-5'-二磷酸二钠盐Adenosine-5'-diphosphatedisodiumsalt(ADPNa)16178-48-6>95.0%,BR
5'-二磷酸腺苷二钠/腺苷-5'-二磷酸二钠盐Adenosine-5'-diphosphatedisodiumsalt(ADPNa)16178-48-6>95.0%,BR
5'-二磷酸腺苷二钠/腺苷-5'-二磷酸二钠盐Adenosine-5'-diphosphatedisodiumsalt(ADPNa)16178-48-6>95.0%,BR
5'-二磷酸腺苷/腺苷-5'-二磷酸Adenosine5'-(trihydrogendiphosphate)/ADP58-64-0>95.0%,BR
5'-二磷酸腺苷/腺苷-5'-二磷酸Adenosine5'-(trihydrogendiphosphate)/ADP58-64-0>95.0%,BR
5'-二磷酸腺苷/腺苷-5'-二磷酸Adenosine5'-(trihydrogendiphosphate)/ADP58-64-0>95.0%,BR
沙格列汀/沙克列汀Saxagliptin361442-04-8>98%,BR
沙格列汀/沙克列汀Saxagliptin361442-04-8>98%,BR
羟丙基甲基纤维素/羟丙甲纤维素HydroxyPropylMethylCellulose/HPMCE509004-65-3甲氧基含量28.0%-30.0%,羟丙基含量7.0%-12.0%,粘度40-60mPas,USP32(2910)
羟丙基甲基纤维素/羟丙甲纤维素HydroxyPropylMethylCellulose/HPMCE509004-65-3甲氧基含量28.0%-30.0%,羟丙基含量7.0%-12.0%,粘度40-60mPas,USP32(2910)
羟丙基甲基纤维素/羟丙甲纤维素HydroxyPropylMethylCellulose/HPMCK15M9004-65-3甲氧基含量19.0%-24.0%,羟丙基含量4.0%-12.0%,粘度11250-21000mPas,USP32(2208)
羟丙基甲基纤维素/羟丙甲纤维素HydroxyPropylMethylCellulose/HPMCK15M9004-65-3甲氧基含量19.0%-24.0%,羟丙基含量4.0%-12.0%,粘度11250-21000mPas,USP32(2208)
更昔洛韦Ganciclovir82410-32-0>98.5%,BR,可用于细胞培养
更昔洛韦Ganciclovir82410-32-0>98.5%,BR,可用于细胞培养
更昔洛韦Ganciclovir82410-32-0>98.5%,BR,可用于细胞培养
5,6-二甲基-1-茚酮5,6-Dimethoxy-1-indanone2107-69-9>99%
5,6-二甲基-1-茚酮5,6-Dimethoxy-1-indanone2107-69-9>99%
5,6-二甲基-1-茚酮5,6-Dimethoxy-1-indanone2107-69-9>99%
芍药苷(标准品)Paeoniflorin23180-57-6>98%,分析标准品
芍药苷(40%)Paeoniflorin23180-57-6≥40%
芍药苷(40%)Paeoniflorin23180-57-6≥40%
芍药苷(40%)Paeoniflorin23180-57-6≥40%
芍药苷(50%)Paeoniflorin23180-57-6≥50%,BR
芍药苷(50%)Paeoniflorin23180-57-6≥50%,BR
芍药苷(50%)Paeoniflorin23180-57-6≥50%,BR
芍药苷(90%)Paeoniflorin23180-57-6≥90%
芍药苷(90%)Paeoniflorin23180-57-6≥90%
芍药苷(98%)Paeoniflorin23180-57-6>98%,BR
芍药苷(98%)Paeoniflorin23180-57-6>98%,BR
芍药苷(98%)Paeoniflorin23180-57-6>98%,BR
5-羟基色氨酸,5-HTP5-Hydroxytryptophan4350-09-8≥99.0%,BR,L构型
5-羟基色氨酸,5-HTP5-Hydroxytryptophan4350-09-8≥99.0%,BR,L构型
5-羟基色氨酸,5-HTP5-Hydroxytryptophan4350-09-8≥99.0%,BR,L构型
组胺二盐酸盐Histaminedihydrochloride56-92-8>98.5%,BR
组胺二盐酸盐Histaminedihydrochloride56-92-8>98.5%,BR
组胺二盐酸盐Histaminedihydrochloride56-92-8>98.5%,BR
酒石酸卡巴拉汀Rivastigminetartrate129101-54-8≥98%
酒石酸卡巴拉汀Rivastigminetartrate129101-54-8≥98%
酒石酸卡巴拉汀Rivastigminetartrate129101-54-8≥98%
咖啡酸Caffeicacid331-39-5≥99.0%,BR
咖啡酸Caffeicacid331-39-5≥99.0%,BR
咖啡酸Caffeicacid331-39-5≥99.0%,BR
硫酸新霉素Neomycinsulfate1405-10-3≥600I.U./mg,USP34,BR
硫酸新霉素Neomycinsulfate1405-10-3≥600I.U./mg,USP34,BR
硫酸新霉素Neomycinsulfate1405-10-3≥600I.U./mg,USP34,BR
盐酸苯海拉明Diphenhydraminehydrochloride147-24-0>98%,USP32
盐酸苯海拉明Diphenhydraminehydrochloride147-24-0>98%,USP32
盐酸苯海拉明Diphenhydraminehydrochloride147-24-0>98%,USP32
聚肌苷酸Polyinosinicacid30918-54-8≥90.0%,BR
聚肌苷酸Polyinosinicacid30918-54-8≥90.0%,BR